Skip to Main Content

Paper Details

Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
Journal of Clinical Oncology
24
2022
Anti-CD20, B cells, B-cell, B.1.1.529, CLL, Chronic Lymphocytic Leukemia, Delta, N, NHL, Non-Hodgkin Lymphoma, Omicron, Patients, Peripheral blood B-cell, SARS, SARS-CoV, SARS-CoV-2, WA1, anti-CD20, anti-SARS-CoV-2 spike immunoglobulin G-binding, chronic lymphocytic leukemia, circulating B cells, mRNA, non-Hodgkin lymphoma, patients
Author NameAffiliation
Lilin LaiEmory University School of Medicine
Lilin LaiEmory University Schools of Medicine
Lilin LaiYerkes National Primate Research Center
Mehul S SutharEmory University School of Medicine
Mehul S SutharEmory University Schools of Medicine
Rafi AhmedEmory University School of Medicine
  • 1 - 6

Datasets

Release 1.2